The MHRA has advised that they found no evidence to support routine removal of PIP breast implants and they recommended that any patients who were concerned about their implant should seek clinical advice from their consultant surgeon.
HCA International’s leadership supports the MHRA’s position, and has today issued a commitment to any patients that have had PIP breast implant surgery at one of its hospitals, saying that it will provide full support to address their concerns.
HCA is working closely with its consultants and patients to ensure it finds the most appropriate solution for each individual. If any patients require clinical investigation or further surgical support, including the removal of the PIP implant due to clinical need, HCA will meet the cost incurred.
Michael Neeb, President and Chief Executive, HCA International, comments: “We recognise that there is a high level of concern amongst patients who have received PIP implants and we are determined to do everything in our power to address these concerns. HCA has built its name providing clinical services of the highest quality to its patients and we have a duty of care to all of them.”
“The safety and well-being of HCA patients remains our highest priority.”